(Q35824493)

10 August 2017

1 reference

title

Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention (English)

1 reference

systemic lupus erythematosus

10 August 2017

0 references

1 reference

1 reference

M Aringer

1

1 reference

PubMed ID

15230290

10 August 2017

J S Smolen

series ordinal

2

1 reference

PubMed ID

15230290

10 August 2017

language of work or name

1 reference

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

13

1 reference

10 August 2017

344-347

1 reference

10 August 2017

5

1 reference

Anti-DNA and autoantibodies

10 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Tumor necrosis factor in the serum of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Renal expression of IL-6 and TNFalpha genes in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee: comparison of standing anteroposterior and Lyon schuss views

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Tumour necrosis factor and other cytokines in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Interleukin 6 promotes murine lupus in NZB/NZW F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1024OA

10.1191/0961203303LU1024OA

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15230290